Jennifer Pietenpol

February 24, 2026

Vanderbilt University School of Medicine ranks seventh in NIH support of disease-fighting research

Six clinical departments and two basic science departments at VUSM ranked in the top 10 among medical school departments nationwide in fiscal year 2025.  

By Bill Snyder
(Photo credit: iStock photo)
June 26, 2025

Three VUMC researchers receive Komen leadership grants

The grants support 25 cutting-edge projects at 17 institutions — marking a powerful commitment to improving outcomes for people living with breast cancer today and in the future.

By Tom Wilemon
Jennifer Pietenpol, PhD, speaks during the event celebrating the unveiling of her portrait. (photo by Donn Jones)
January 30, 2025

Portrait unveiling honors Jennifer Pietenpol  

During her tenure, Vanderbilt-Ingram experienced remarkable growth, including a 100% increase in research funding and a 160% expansion in inpatient visits.

By Tom Wilemon
Spring Donor Celebration attendees included, from left, Owen Canavan, Meghan Hibey, Beth Canavan and Karl Canavan. (photo by Erin O. Smith)
May 15, 2024

Event honors donors’ ongoing support, generosity

Members of Vanderbilt University Medical Center’s Canby Robinson Society recently joined CEO and President Jeff Balser, MD, PhD, and his wife, Melinda, at Cheekwood Botanic Hall for the Spring Donor Celebration, an annual event honoring donors for their loyal support.

By Nancy Humphrey
Jennifer Pietenpol, PhD
April 5, 2024

Pietenpol to receive ASCO’s highest honor

Jennifer Pietenpol, PhD, will be recognized at the annual meeting of the American Society of Clinical Oncology (ASCO) with one of its highest honors.

By Tom Wilemon
January 29, 2024

Expanded space boosts cutting-edge research in infectious diseases and immunology

The Vanderbilt Institute for Infection, Immunology and Inflammation recently debuted state-of-the-art new facilities in Medical Center.

By Leigh MacMillan
December 15, 2023

Clinical trial shows efficacy for atezolizumab combined with carboplatin

By Tom Wilemon
March 22, 2022

VUMC’s Pietenpol, Shyr named AACR Fellows

Vanderbilt's Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy.
By Tom Wilemon
February 17, 2022

Park named director of Vanderbilt-Ingram Cancer Center

Ben Ho Park, MD, PhD, deputy director of the Vanderbilt-Ingram Cancer Center, has been named the center’s new director.
By John Howser
February 10, 2022

Pietenpol named chief scientific and strategy officer

Jennifer Pietenpol, PhD, director of the Vanderbilt-Ingram Cancer Center (VICC), Benjamin F. Byrd Jr. Professor of Oncology and Executive Vice President for Research for Vanderbilt University Medical Center, is stepping down on June 30 from her long-held role as the Cancer Center’s director to focus on a combined leadership role for VUMC as chief scientific and strategy officer (CSSO).
By John Howser
November 18, 2021

‘Multi-omics’ reveals treatment option for breast cancer subtype

By Bill Snyder
September 2, 2021

Discovery offers insight for development of cancer therapies targeting mutant p53

Vanderbilt researchers have discovered that aneuploidy (an abnormal number of chromosomes) drives malignant phenotypes in cells expressing mutant p53, a tumor suppressor protein that is mutated in more than half of all human cancers.
By Bill Snyder
August 19, 2021

Expression atlas for cell regulators

Vanderbilt researchers report a comprehensive tissue-specific atlas of protein and mRNA expression for p63 and p73, members of the p53 family signaling network that is the most frequent target of mutations in human cancers.
By Leigh MacMillan